Full Text View
Tabular View
No Study Results Posted
Related Studies
A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects
This study has been completed.
Study NCT00894660   Information provided by Pfizer

First Received on May 4, 2009.   Last Updated on April 20, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Falciparum Malaria
Additional conditions recognized in this trial
Malaria
Malaria, Falciparum
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
Amodiaquine (Test)
Amodiaquine (Comparator)
Additional drug interventions recognized in this trial
Amodiaquine
More general drug interventions related to this trial
Anti-Infective Agents
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services